HIV Infections trials in Russia: Trial Insights

Filters: Condition: HIV Infections Country / region: Russia Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2000	1
2001	2
2002	2
2003	3
2004	2
2005	2
2006	2
2007	4
2008	3
2009	2
2010	4
2012	4
2013	3
2014	2
2015	5
2016	5
2017	2
2018	4
2019	2
2020	3
2021	2
2023	2

Trials by status
Category	Trials
Completed	50
Active, not recruiting	5
Terminated	4
Unknown status	2
Approved for marketing	1

Top lead sponsors
Category	Trials
ViiV Healthcare	21
Boston Medical Center	9
Bristol-Myers Squibb	4
Tibotec Pharmaceuticals, Ireland	4
GlaxoSmithKline	3
Boehringer Ingelheim	2
Gilead Sciences	2
Janssen-Cilag International NV	2
Merck Sharp & Dohme LLC	2
Central Clinical Hospital of the Russian Academy of Sciences	1

Top conditions
Category	Trials
HIV Infections	62
Acquired Immunodeficiency Syndrome	21
Infections	12
Substance-Related Disorders	5
Inflammation	4
Tuberculosis	3
Hepatitis C	2
Pain	2
Sexually Transmitted Diseases	2
Angina, Stable	1

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients NCT00110877Phase 3CompletedTibotec Pharmaceuticals, IrelandStarted 2005
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection NCT00089583Phase 2CompletedViiV HealthcareStarted 2004
A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients. NCT00144105Phase 2TerminatedBoehringer IngelheimStarted 2004
RCT of Russian IDU Peer Network HIV Prevention Intervention - 1 NCT00218673Phase 3CompletedJohns Hopkins Bloomberg School of Public HealthStarted 2003
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects NCT00071760Phase 2CompletedViiV HealthcareStarted 2003
HIV Prevention Within High-Risk Bulgarian and Hungarian Social Networks NCT00310973Phase 2/3CompletedMedical College of WisconsinStarted 2003
Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations NCT00710060Phase 3CompletedRTI InternationalStarted 2002
HIV Prevention Preparedness Study in Russia, China, and India NCT00021775ObservationalCompletedNational Institute of Allergy and Infectious Diseases (NIAID)Started 2002
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine NCT00013897Phase 3CompletedBristol-Myers SquibbStarted 2001
Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) NCT00116298Phase 3CompletedBristol-Myers SquibbStarted 2001
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients NCT00005918Phase 3CompletedBristol-Myers SquibbStarted 2000
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. NCT00245739Expanded accessApproved for marketingTibotec Pharmaceuticals, Ireland

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory

HIV Infections trials in Russia

Trials started per year

Status

Top lead sponsors

Top conditions

Trials

Recently changed trials

Go deeper on Pharma Observatory